This pricing is market-based though; if the market won't support it, the price won't exist. The parent's complaint is strange in that light: it's someone lamenting the loss of apparently vastly under-priced software, but framing it as unjust.
It may be so.Bu then again,JIRA is essentially an app that allows to drag a fancy digital post-it across 3 different stages..Yet somehow it is Atlassian booked 800M revenue last year...
JIRA is much more complex than that; unlike with BioRender, yours is an unfair simplification. Your argument can be rescued though by replacing JIRA with Trello.
It is a clip art application with a monthly subscription cost. It seems like a pretty on-the-mark comment.